Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Biological Therapy for Rheumatoid Arthritis - ppt download
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis | NEJM
The value of rituximab treatment in primary Sjögren's syndrome - ScienceDirect
2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis | Reumatología Clínica
Rituximab - Wikipedia
Biological Activity of Rituximab - Rheumatoid Arthritis | Biology activity, Biological activity, Rheumatoid arthritis
Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis. | Semantic Scholar
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience | Annals of the Rheumatic Diseases
Rituximab - Wikipedia
Current perspective on rituximab in rheumatic diseases | DDDT
References in New therapies for treatment of rheumatoid arthritis - The Lancet
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
